| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2050595 | A | Metabolic stability of the compound in human serum at 0.5 mM after 3 hrs by RP-HPLC analysis | Homo sapiens | 6 | cell-free format | Scientific Literature | ||
| 2. | ALA2050597 | P | Lipophilicity, log D of the compound at pH 7.4 by shake-flask method | 5 | small-molecule physicochemical format | Scientific Literature | |||
| 3. | ALA2050598 | F | Antioxidant activity against CuSO4-induced LDL oxidation assessed as delta-lag time at 100 uM by spectrophotometric analysis | 5 | assay format | Scientific Literature | |||
| 4. | ALA2050599 | F | Antioxidant activity against CuSO4-induced LDL oxidation measured per mg of LDL product assessed as propagation rate of the oxidation at 100 uM by spectrophotometric analysis | 5 | assay format | Scientific Literature | |||
| 5. | ALA2050600 | F | Antioxidant activity assessed as (E)-4-hydroxy-trans-2,3-nonenal scavenging activity in phosphate buffer at pH 7.4 at 1 mM after 24 hrs by reverse-phase HPLC analysis relative to control | 5 | assay format | Scientific Literature | |||
| 6. | ALA2050601 | F | Vasodilator activity in Wistar rat endothelium-denuded thoracic aorta assessed as inhibition of L-phenylephrine-induced contraction | Rattus norvegicus | 7 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!